Folic acid associated with decreased risk of cognitive impairment
Homocysteine concentrations in the blood appear to be associated with higher risk of vascular disease, which in turn might
play a role in vascular dementia and in Alzheimer’s Disease. If so, then one might expect that supplements which decrease
homocysteine levels would also decrease the incidence of vascular dementia and Alzheimer’s. A new study now confirms that
this is the case.
Folic acid is a vitamin that has a known suppressive effect on homocysteine production in the body. In elderly subjects, higher
folic acid in the blood were associated with lower incidence of vascular dementia and of Alzheimer’s Disease.
Link to research summary:
Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia
LifeLink carries folic acid in 5 mg capsules.